Prime Medicine, Inc.
PRME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$196 | -$198 | -$122 | -$165 |
| Dep. & Amort. | $6 | $5 | $2 | $1 |
| Deferred Tax | $0 | -$0 | -$1 | -$1 |
| Stock-Based Comp. | $26 | $14 | $6 | $2 |
| Change in WC | $31 | $3 | -$35 | $31 |
| Other Non-Cash | $10 | $12 | $18 | $98 |
| Operating Cash Flow | -$123 | -$165 | -$132 | -$34 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$9 | -$16 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$129 | -$105 | -$123 | -$82 |
| Inv. Sales/Matur. | $204 | $133 | $93 | $13 |
| Other Inv. Act. | $1 | -$0 | -$1 | -$0 |
| Investing Cash Flow | $68 | $19 | -$47 | -$74 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $170 | $1 | $185 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $26 | $0 | -$4 | $269 |
| Financing Cash Flow | $196 | $1 | $181 | $269 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $141 | -$146 | $3 | $162 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55 | $201 | $199 | $37 |
| End Cash | $197 | $55 | $201 | $199 |
| Free Cash Flow | -$130 | -$174 | -$148 | -$38 |